Show simple item record

dc.contributor.authorPérez-Nadales, Elena
dc.contributor.authorAlastruey-Izquierdo, Ana
dc.contributor.authorLinares-Sicilia, María José
dc.contributor.authorSoto-Debrán, Juan Carlos
dc.contributor.authorAbdala, Edson
dc.contributor.authorGarcía-Rodríguez, Julio
dc.contributor.authorMontejo, Miguel
dc.contributor.authorMuñoz, Patricia
dc.contributor.authorSalavert Lletí, Miguel
dc.contributor.authorRezusta, Antonio
dc.contributor.authorRuiz Pérez de Pipaón, Maite
dc.contributor.authorYáñez, Lucrecia
dc.contributor.authorMerino, Esperanza
dc.contributor.authorCampos-Herrero, María Isolina
dc.contributor.authorCosta-Mateo, José María
dc.contributor.authorFortún, Jesús
dc.contributor.authorGarcía-Lozano, Tomás
dc.contributor.authorGarcia-Vidal, Carolina
dc.contributor.authorFernández-Ruiz, Mario
dc.contributor.authorSánchez-Reus, Ferrán
dc.contributor.authorCastro-Méndez, Carmen
dc.contributor.authorGuerrero Lozano, Inmaculada 
dc.contributor.authorSoler-Palacín, Pere
dc.contributor.authorAguado, José María
dc.contributor.authorMartínez-Martínez, Luis
dc.contributor.authorTorre-Cisneros, Julian
dc.contributor.authorNucci, Marcio
dc.contributor.authorSpanish Fusariosis Study Group
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2021-02-18T12:43:48Z
dc.date.available2021-02-18T12:43:48Z
dc.date.issued2021-01
dc.identifier.issn1080-6040
dc.identifier.issn1080-6059 (internet)
dc.identifier.urihttp://hdl.handle.net/10498/24512
dc.description.abstractInvasive fusariosis (IF) is associated with severe neutropenia in patients with concurrent hematologic conditions. We conducted a retrospective observational study to characterize the epidemiology of IF in 18 Spanish hospitals during 2000-2015. In that time, the frequency of IF in nonneutropenic patients increased from 0.08 cases per 100,000 admissions in 2000-2009 to 0.22 cases per 100,000 admissions in 2010-2015. Nonneutropenic IF patients often had nonhematologic conditions, such as chronic cardiac or lung disease, rheumatoid arthritis, history of solid organ transplantation, or localized fusariosis. The 90-day death rate among nonneutropenic patients (28.6%) and patients with resolved neutropenia (38.1%) was similar. However, the death rate among patients with persistent neutropenia (91.3%) was significantly higher. We used a multivariate Cox regression analysis to characterize risk factors for death: persistent neutropenia was the only risk factor for death, regardless of antifungal therapy.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherCENTERS DISEASE CONTROL & PREVENTIONes_ES
dc.sourceEmerging Infectious Diseases Vol. 27, No. 1, January 2021es_ES
dc.titleInvasive Fusariosis in Nonneutropenic Patients, Spain, 2000-2015es_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3201/eid2701.190782
dc.relation.projectIDPlan Nacional de I+D+I 2013-2016es_ES
dc.relation.projectIDInstituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Ciencia, Innovacion y Universidades, Spanish Network for Research in Infectious Diseases [REIPI RD16/0016/0008]es_ES
dc.relation.projectIDInstituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Ciencia, Innovacion y Universidades, Spanish Network for Research in Infectious Diseases [RD16/CIII/0004/0003]es
dc.relation.projectIDEuropean Development Regional Fund "A way to achieve Europe," Operative Program Intelligent Growth 2014-2020es_ES
dc.relation.projectIDInstituto de Salud Carlos III [CP18/00073]es_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record